Xiaojie Wu
Fudan University(CN)Fudan University Shanghai Cancer Center(CN)Binzhou People's Hospital(CN)Hangzhou DAC Biotech (China)(CN)Huashan Hospital(CN)Anhui Normal University(CN)
Publications by Year
Research Areas
Antibiotics Pharmacokinetics and Efficacy, Antibiotic Resistance in Bacteria, Pneumonia and Respiratory Infections, Antimicrobial Resistance in Staphylococcus, Biosimilars and Bioanalytical Methods
Most-Cited Works
- → Hepatic Krüppel-like factor 16 (KLF16) targets PPARα to improve steatohepatitis and insulin resistance(2020)126 cited
- → Ginsenoside Rg2 Ameliorates High-Fat Diet-Induced Metabolic Disease through SIRT1(2020)62 cited
- → Acute toxicity is a dose-limiting factor for intravenous polymyxin B: A safety and pharmacokinetic study in healthy Chinese subjects(2021)51 cited
- → Development and validation of a UHPLC–MS/MS assay for colistin methanesulphonate (CMS) and colistin in human plasma and urine using weak-cation exchange solid-phase extraction(2016)42 cited
- → Population Pharmacokinetics and Dosing Regimen Optimization of Meropenem in Cerebrospinal Fluid and Plasma in Patients with Meningitis after Neurosurgery(2016)42 cited
- → Safety and Clinical Pharmacokinetics of Nemonoxacin, a Novel Non-Fluorinated Quinolone, in Healthy Chinese Volunteers Following Single and Multiple Oral Doses